Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.98 USD | +18.85% | +11.16% | +101.62% |
May. 16 | Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise | MT |
May. 09 | Transcript : Ventyx Biosciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 351M |
---|---|---|---|---|---|
Net income 2024 * | -160M | Net income 2025 * | -183M | EV / Sales 2024 * | - |
Net cash position 2024 * | 224M | Net cash position 2025 * | 396M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.05
x | P/E ratio 2025 * |
-1.9
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.82% |
Latest transcript on Ventyx Biosciences, Inc.
1 day | +18.85% | ||
1 week | +11.16% | ||
Current month | +33.16% | ||
1 month | +4.62% | ||
3 months | +102.44% | ||
6 months | +111.02% | ||
Current year | +101.62% |
Managers | Title | Age | Since |
---|---|---|---|
Raju Mohan
FOU | Founder | 68 | 18-10-31 |
Martin Auster
DFI | Director of Finance/CFO | 49 | 21-04-30 |
John Nuss
CTO | Chief Tech/Sci/R&D Officer | 65 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Somu Subramaniam
BRD | Director/Board Member | 69 | 18-10-31 |
Allison Hulme
BRD | Director/Board Member | 61 | 23-01-10 |
Sheila Gujrathi
CHM | Chairman | 53 | 21-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 4.98 | +18.85% | 1,393,674 |
24-05-15 | 4.19 | +0.48% | 435,422 |
24-05-14 | 4.17 | +1.21% | 635,017 |
24-05-13 | 4.12 | +0.73% | 814,759 |
24-05-10 | 4.09 | -8.71% | 910,786 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+101.62% | 351M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- VTYX Stock